Prelude Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-291,332
| Closed | -$201K | – | 1522 |
|
|
2020
Q4 | $201K | Buy |
291,332
+52,946
| +22% | +$36.5K | 0.01% | 671 |
|
|
2020
Q3 | $536K | Sell |
238,386
-88,557
| -27% | -$199K | 0.03% | 278 |
|
|
2020
Q2 | $1.17M | Buy |
326,943
+180,427
| +123% | +$646K | 0.06% | 132 |
|
|
2020
Q1 | $557K | Sell |
146,516
-63,274
| -30% | -$241K | 0.04% | 165 |
|
|
2019
Q4 | $631K | Buy |
+209,790
| New | +$631K | 0.02% | 272 |
|